This inventor holds 1 USPTO granted patent. Top assignee: Rinat Neuroscience Corporation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Jacob Eli Gunn Glanville: Innovator in Antibody Therapeutics
Introduction
Jacob Eli Gunn Glanville is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of antibody therapeutics, particularly in the development of antagonizing antibodies that target alpha-toxin. His work is crucial in addressing various staphylococcal diseases.
Latest Patents
Jacob holds 1 patent that provides a method for obtaining antibodies that bind to alpha-toxin. This invention also includes antibody encoding nucleic acids and therapeutic methods for using these antibodies to treat and prevent conditions such as pneumonia, bacteremia, sepsis, eye infections, and abscesses.
Career Highlights
Jacob is currently associated with Rinat Neuroscience Corporation, where he continues to advance his research in antibody therapeutics. His innovative approach has the potential to significantly impact the treatment of staphylococcal diseases.
Collaborations
Jacob collaborates with notable colleagues, including Davide Foletti and Javier Fernando Chaparro Riggers. Their combined expertise enhances the research and development efforts at Rinat Neuroscience Corporation.
Conclusion
Jacob Eli Gunn Glanville is a key figure in the field of antibody therapeutics, with a focus on innovative solutions for staphylococcal diseases. His contributions are paving the way for new treatment options and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile